Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.


NDAQ:XXII - Post by User

Post by lelianicruzon Sep 23, 2024 10:56am
31 Views
Post# 36236367

$XXII Expands in Southeast Asia with Moonlight Brand

$XXII Expands in Southeast Asia with Moonlight Brand

22nd Century Group, Inc. (NASDAQ: XXII) has secured a significant new customer agreement to supply its Moonlight branded cigarettes in Southeast Asia. This strategic move is expected to boost factory volumes by over 30% once fully scaled. The initial shipment is anticipated in Q4 2024, with further expansions planned throughout 2025. The company's Chairman and CEO, Larry Firestone, emphasized leveraging their in-house brand assets in a region with a robust smoking culture.

This expansion is part of a broader strategy to introduce additional brands and collaborate on reduced nicotine products globally. The company has already made headway in South Korea, reflecting its commitment to harm reduction.

22nd Century’s flagship VLN® cigarette, containing 95% less nicotine, is the only combustible cigarette authorized by the FDA to aid in reducing smoking rates. This unique product aligns with the company’s mission to offer smokers better control over their nicotine intake.

As of the latest market data, 22nd Century Group’s stock ($XXII) is trading at [insert current price], with a market capitalization of [insert market cap]. The company's innovative approach positions it strongly in the global tobacco market, catering to changing regulatory and consumer landscapes.

<< Previous
Bullboard Posts
Next >>